Debate: Albumin administration should be avoided in the critically ill
The benefit of albumin administration in the critically ill patient is unproven. Epidemiological evidence suggests that there is an increase in death among patients with burns, hypoalbuminaemia, and hypotension treated with human albumin solution (HAS). In critical illness, hypoalbuminaemia is a res...
保存先:
| 出版年: | Crit Care |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2000
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC137253/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11211856/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/cc688 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|